Summary:
A clinical research study of an adjunctive investigational medicine for schizophrenia in subjects who have experienced weight gain from Risperdal, Seroquel, or Zyprexa over the last 12 months.
Qualified Participants Must:
• Ages 18-65
•
Currently being treated with Risperdal, Seroquel, or Zyprexa
•
Experienced weight gain over the last 12 months
Qualified Participants May Receive:
Transportation & Compensation at each study visit